Business · 19/09/2024Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting for Strain Selection of Influenza Vaccines
Summary
The FDA is hosting a public advisory committee meeting to discuss strain selection for influenza vaccines, with at least one portion of the meeting closed to the public, and is seeking public comments on the topic.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →